How To Invest In Abbott Stocks From India

Abbott India is a pharmaceutical company that was incorporated in 1944. It officially entered India during the year 1910 and soon became widely known for high-quality medicines.

Believe it or not, but Abbott India went through several rounds of name changes before adopting the name that it’s known by today. That’s not the only thing that has changed, however. 

Abbott India’s stock price has grown from 506 back in 1999 to a mammoth 18,758.20 as of August 2021. In this story, we’ll help you find out how to invest in Abbott India stock. 

The Fundamentals Of Abbott India Stock

1. Stock Name: Abbott India Ltd. (ABBOTINDIA)

2. Share Price: ₹18,758.20*

3. Market Cap: ₹40,469 crores ($5.44 billion)

4. Dividend Yield: 1.44

5. Beta: 0.13

6. 52 Week Low: ₹19,140.00

7. 52 Week High: ₹18,730.05

Fun Fact: Abbott India has a higher market capitalization than companies like Hindustan Petroleum, Madras Rubber Factory, IDFC FIRST Bank, and US companies like Papa John's Pizza. 

Abbott India Stock Price From 1999 To 2021

Fun fact: Abbott India was originally called the Boots Pure Drug Company (India) Limited.

How Are Abbott India Stock Prices?

Abbott India stock price has grown by more than 19% from January 1st, 2021 to August 17th, 2021 (year to date). That’s relatively less compared to its top peers like: 

• Sun Pharma (31%)
• Divi's Laboratories Ltd (27%)   
  

On the other hand, Abbott India’s stock growth (year to date) is better than its top competitors like:

• Dr Reddy's Labs (-10%)
• Cipla (9.24%)
  

Abbott India also has a solid EPS. In fact, it’s in the top 15 stocks with the best TTM EPS in India. Earnings per share is a measure of a company’s profitability. Higher the EPS, the better the company. 

Is Abbott India Stock A Good Buy?

Abbott India’s revenue for the quarter ended June 2021 stood at ₹1,217.83 crores. That’s a significant improvement from the previous year (same quarter), up from ₹1,064.27 crores by approximately 14%. 

Furthermore, Abbott India has also registered a healthy quarter on quarter growth. Its revenue grew from ₹1,095.54 crores in the March 2021 quarter to ₹ 1,217.83 crores, which is a jump of 11.16%. 

Does Abbott India Stock Fit Into Your Portfolio?

Abbott India’s financials are solid but in the pharmaceutical industry, there’s no such thing as a free lunch. Admittedly, ABBOTINDIA has been known to be consistent. 

However, the launch of a new breakthrough drug by a competitor or failure in clinical trials may impact the stock price. Add to the fact that this is a direct stock which means it may experience short term volatility.

Thus, it’s wise to get your risk profile and investment goals evaluated before buying a pharmaceutical stock like Abbott India. Furthermore, it’s important to identify whether the ABBOTINDIA stock will fit in your current portfolio. 

Top Ways To Buy Abbott Stock From India

Broadly speaking, you can invest in Abbott India shares in 3 ways.

1. Mutual Funds

Buying an Abbott India share may be relatively costly for several investors. However, they can reap the benefits of the ABBOTINDIA stock through mutual funds that hold the stock. 

2. Equity Advisor

The pharma industry is a tough nut to crack if you’re an investor with limited time for research. Truth be told, identifying the right pharma stock for your portfolio would take up a lot of man-hours. 

That’s why busy professionals can benefit from getting advice from IAs like Purnartha. An investment advisor recommends stocks that can fit your goals and risk profile.

PMS is an option for investors who want greater flexibility and services for their portfolios. PMS entities like Marcellus or Ambit Capital can help you figure out if you should invest in Abbott India stock.

Note:

Facts & figures are true as of 17-08-2021. All information mentioned is for educational purposes and relies on publicly available information. None of the information shared here is to be construed as investment advice. We strongly recommend you consult a Cube Wealth coach before investing your money in any stock, mutual fund. PMS or alternative asset.